Patents by Inventor Jonathan Weinstein

Jonathan Weinstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12074843
    Abstract: Embodiments provide a social networking platform offering various services, such as, facilitating aggregation and management of a user's interaction on one or more social networking platforms, offering enhanced control over the level of privacy associated with the flow of user data, offering tools to customize the user's exposure to advertisement-related content on the social networking platform(s), integrating features to control aspects of how data/content is presented to and visualized by the user, empowering the user to multicast direct messages to other users without the other users having to meet certain constraints, empowering the user to create and/or join a group based on messaging threads, and the like. One or more of these enhanced services/features are associated with a powerful framework of authentication/permission model for access control.
    Type: Grant
    Filed: April 17, 2023
    Date of Patent: August 27, 2024
    Assignee: SGROUPLES, INC.
    Inventors: Jonathan Wolfe, Mark Weinstein
  • Publication number: 20230045322
    Abstract: Neuroinflammation mediated by microglia and infiltrating peripheral immune cells is a major component of stroke pathophysiology. The calcium activated potassium channel KCa3.1 is expressed selectively in the injured CNS by microglia, and KCa3.1 function has been implicated in proinflammatory activation of microglia. KCa3.1 is further implicated in the pathophysiology of ischemia/reperfusion (stroke) related brain injury. Senicapoc, an investigational drug with a proven safety profile and shown to cross the blood-brain barrier, is a potent and selective KCa3.1 inhibitor that intervenes in the inflammation cascade that follows ischemia/reperfusion, and is a potential treatment for stroke.
    Type: Application
    Filed: July 18, 2022
    Publication date: February 9, 2023
    Inventors: Roland STAAL, Jonathan WEINSTEIN, Thomas MOELLER
  • Patent number: 11395807
    Abstract: Neuroinflammation mediated by microglia and infiltrating peripheral immune cells is a major component of stroke pathophysiology. The calcium activated potassium channel KCa3.1 is expressed selectively in the injured CNS by microglia, and KCa3.1 function has been implicated in proinflammatory activation of microglia. KCa3.1 is further implicated in the pathophysiology of ischemia/reperfusion (stroke) related brain injury. Senicapoc, an investigational drug with a proven safety profile and shown to cross the blood-brain barrier, is a potent and selective KCa3.1 inhibitor that intervenes in the inflammation cascade that follows ischemia/reperfusion, and is a potential treatment for stroke.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: July 26, 2022
    Inventors: Roland Staal, Jonathan Weinstein, Thomas Moller
  • Publication number: 20200000749
    Abstract: Neuroinflammation mediated by microglia and infiltrating peripheral immune cells is a major component of stroke pathophysiology. The calcium activated potassium channel KCa3.1 is expressed selectively in the injured CNS by microglia, and KCa3.1 function has been implicated in proinflammatory activation of microglia. KCa3.1 is further implicated in the pathophysiology of ischemia/reperfusion (stroke) related brain injury. Senicapoc, an investigational drug with a proven safety profile and shown to cross the blood-brain barrier, is a potent and selective KCa3.1 inhibitor that intervenes in the inflammation cascade that follows ischemia/reperfusion, and is a potential treatment for stroke.
    Type: Application
    Filed: January 30, 2018
    Publication date: January 2, 2020
    Inventors: Roland STAAL, Jonathan WEINSTEIN, Thomas MOLLER
  • Patent number: 6640926
    Abstract: An elbow silencer is disclosed comprising a casing and a baffle defining a flow channel. The elbow silencer is constructed to be modular so that two or more complementary elbow silencers are capable of engaging in a nesting relationship. The nested, complementary elbow silencers comprise substantially similar flow channels to produce predictable acoustic attenuation, self generated noise and pressure loss.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: November 4, 2003
    Assignee: Industrial Acoustics Company, Inc.
    Inventor: Jonathan Weinstein
  • Publication number: 20020084138
    Abstract: An elbow silencer is disclosed comprising a casing and a baffle defining a flow channel. The elbow silencer is constructed to be modular so that two or more complementary elbow silencers are capable of engaging in a nesting relationship. The nested, complementary elbow silencers comprise substantially similar flow channels to produce predictable acoustic attenuation, self generated noise and pressure loss.
    Type: Application
    Filed: December 29, 2000
    Publication date: July 4, 2002
    Inventor: Jonathan Weinstein
  • Patent number: 4794206
    Abstract: In a room that is RF shielded and acoustically insulated, a plurality of panels are fastened together to form a self-supported structure. The panels are fabricated from a continuous metal sheathing and filled with acoustic insulating material. The panels are fastened together by joiners and compression clamps. Structural steel tubing can be fastened between the panels when additional structural strength is required. Access to the interior of the room is provided by a metal door that is filled with acoustic insulating material. The door also includes both RF and acoustic seals. The door is equipped with special hinges that enable the door to be flush mounted and to be opened 180.degree..
    Type: Grant
    Filed: November 20, 1986
    Date of Patent: December 27, 1988
    Assignee: Industrial Acoustics Company, Inc.
    Inventor: Jonathan Weinstein